BioGend monthly revenue
BioGend
| Period | Released | Revenue (NT$) | MoM % | YoY % | YTD Rev (NT$) |
|---|---|---|---|---|---|
| Jun 2026 | Jul 15, 2026 | NT$0B | +48.7% | +63.6% | NT$0.1B |
| May 2026 | Jun 17, 2026 | NT$0B | -18.3% | -14.5% | NT$0.1B |
| Apr 2026 | May 17, 2026 | NT$0B | +18.0% | +0.9% | NT$0.1B |
| Mar 2026 | Apr 17, 2026 | NT$0B | +8.5% | +10.4% | NT$0.1B |
| Feb 2026 | Mar 17, 2026 | NT$0B | -33.5% | +1.4% | NT$0B |
| Jan 2026 | — | NT$0B | — | +32.9% | NT$0B |
| Dec 2025 | — | NT$0B | — | +15.5% | NT$0.2B |
| Nov 2025 | — | NT$0B | — | +43.8% | NT$0.2B |
| Oct 2025 | — | NT$0B | — | -0.8% | NT$0.2B |
| Sep 2025 | — | NT$0B | — | +55.8% | NT$0.2B |
| Aug 2025 | — | NT$0B | — | +9.7% | NT$0.1B |
| Jul 2025 | — | NT$0B | — | +55.4% | NT$0.1B |
| Jun 2025 | — | NT$0B | — | +59.7% | NT$0.1B |
| May 2025 | — | NT$0B | — | +44.1% | NT$0.1B |
| Apr 2025 | — | NT$0B | — | +28.1% | NT$0.1B |
| Mar 2025 | — | NT$0B | — | -1.9% | NT$0B |
| Feb 2025 | — | NT$0B | — | +79.6% | NT$0B |
| Jan 2025 | — | NT$0B | — | +49.1% | NT$0B |
| Dec 2024 | — | NT$0B | — | +82.5% | NT$0.2B |
| Nov 2024 | — | NT$0B | — | +51.7% | NT$0.1B |
| Oct 2024 | — | NT$0B | — | -3.5% | NT$0.1B |
| Sep 2024 | — | NT$0B | — | +84.1% | NT$0.1B |
| Aug 2024 | — | NT$0B | — | +129.4% | NT$0.1B |
| Jul 2024 | — | NT$0B | — | +113.2% | NT$0.1B |
Values are shown in billions of TWD. Latest period: Jun 2026. Updated 2026-07-29. Source: Company websiteTaiwan public company filings
Monthly Sales is available publicly. Financials, KPIs, reports, transcripts and the rest of Research require the Research tier.